CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
137.01
1.38%
Market Trading Hours* (UTC) Open now
Closes on Tuesday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.51
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023485 %
Charges from full value of position ($-4.46)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023485%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001262 %
Charges from full value of position ($0.24)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001262%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 138.79
Open 135.69
1-Year Change 26.41%
Day's Range 135.45 - 139.71
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 31, 2025 138.79 2.49 1.83% 136.30 140.27 135.36
Mar 28, 2025 140.01 1.01 0.73% 139.00 142.83 138.41
Mar 27, 2025 144.01 -1.73 -1.19% 145.74 148.51 144.01
Mar 26, 2025 148.32 1.22 0.83% 147.10 150.76 146.95
Mar 25, 2025 149.82 0.42 0.28% 149.40 151.87 147.81
Mar 24, 2025 149.77 1.75 1.18% 148.02 150.30 147.77
Mar 21, 2025 146.86 2.18 1.51% 144.68 147.13 142.86
Mar 20, 2025 148.05 1.47 1.00% 146.58 151.31 146.58
Mar 19, 2025 151.13 4.52 3.08% 146.61 152.76 146.58
Mar 18, 2025 148.05 0.22 0.15% 147.83 149.98 146.23
Mar 17, 2025 149.09 10.14 7.30% 138.95 149.50 138.95
Mar 14, 2025 142.98 8.28 6.15% 134.70 143.78 134.70
Mar 13, 2025 140.08 5.28 3.92% 134.80 141.35 134.80
Mar 12, 2025 141.43 -1.61 -1.13% 143.04 144.95 139.43
Mar 11, 2025 138.59 8.57 6.59% 130.02 141.23 127.95
Mar 10, 2025 130.01 -9.32 -6.69% 139.33 140.80 126.72
Mar 7, 2025 141.73 4.88 3.57% 136.85 144.83 136.85
Mar 6, 2025 141.92 3.96 2.87% 137.96 144.93 137.96
Mar 5, 2025 143.52 6.32 4.61% 137.20 144.92 137.20
Mar 4, 2025 140.33 0.38 0.27% 139.95 142.87 135.72

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

ICU Medical Company profile

About ICU Medical Inc

ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. The Company’s product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. Its critical care products help clinicians get real-time access to patients’ hemodynamic and cardiac status with a portfolio of monitoring systems and advanced sensors and catheters. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. It sells its products through its direct sales force and through independent distributors. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, ICU Medical Inc revenues increased 4% to $1.32B. Net income increased 19% to $103.1M. Revenues reflect Infusion Consumables segment increase of 17% to $555.2M, Critical Care segment increase of 1% to $49.3M, United States segment increase of 3% to $941.8M, EMEA segment increase of 11% to $147.5M. Net income benefited from Restructuring Charges/Provisions decrease of 37% to $18M (expense).

Equity composition

Common Stock $.10 Par, 03/11, 80M auth., 14,855,000 issd., less 1,123,000 shs. in Treas @ $38.95M. Insiders & Strategic holders own 11.33%. IPO 3/92, 1.3M shares @ $11.00 by Sutro& Co., Inc. PO 7/95, 2.07M shares @ $12 by Rodman & Renshaw, Inc. 3/02, 4/93, 3-for-2 stock splits. FY'03 Q4 are being restated.

Industry: Medical Equipment, Supplies & Distribution (NEC)

951 Calle Amanecer
SAN CLEMENTE
CALIFORNIA 92673-6212
US

People also watch

ETH/USD

1,923.14 Price
+5.470% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

XRP/USD

2.15 Price
+2.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01073

US100

19,383.10 Price
+0.640% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0013%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

85,325.15 Price
+3.410% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading